Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and bispecific antibodies, today announced new...

Expects Biocon Biologics Transaction to Close Shortly Intends to Begin Executing on Stock Repurchase Program Enters Agreements to Acquire Oyster Point Pharma and Famy Life Sciences for Aggregate...

Your "presents" is requested as Belk once again invites customers to SantaFest at all locations on Saturday, November 12 from 12-3 p.m. This yearly event is Belk's jolly way of kicking off the...

Enara Bio's unique approach identifying Dark Antigen™ candidates and cognate T cells in non-small-cell lung cancer and melanoma detailed in two posters to be presented at the 37th Society for...

Mr. Dai Zheng, its founder, will speak at the forum "Bridging the Digital Divide" BEIJING, Nov. 7, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global...

– IONIS-FB-LRx achieved a 44% mean reduction in proteinuria in patients treated for 6 months – Roche to advance IONIS-FB-LRx into Phase 3 development in H1 2023 CARLSBAD, Calif., Nov. 7, 2022...

─New Preclinical Data Further Supports Ability of CCL24-Neutralizing Antibody CM-101 to Interrupt the Pro-inflammatory Immune Cell Migration that Is Key in Primary Sclerosing Cholangitis─ TEL...

Construction-Focused Cloud Platform is the New Backbone of Trimble Construction One, Enabling Project Teams to Better Design, Construct, Operate and Manage Projects LAS VEGAS, Nov. 7, 2022...

Together Exyn and Trimble Demonstrate a Groundbreaking Solution to Increase Efficiency and Safety Across Complex GNSS-Denied Construction Environments LAS VEGAS, Nov. 7, 2022 /PRNewswire/ --...

CentralNic Group PLC (AIM: CNIC), the company dedicated to building a better global digital economy, is pleased to announce that its CEO Ben Crawford will join the Business 20 ("B20") Summit as...